SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093343
Filing Date
2024-08-08
Accepted
2024-08-08 08:00:24
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20240630.htm   iXBRL 10-Q 1575936
2 EX-31.1 pmvp-ex31_1.htm EX-31.1 16436
3 EX-31.2 pmvp-ex31_2.htm EX-31.2 16195
4 EX-32.1 pmvp-ex32_1.htm EX-32.1 8618
5 EX-32.2 pmvp-ex32_2.htm EX-32.2 8874
  Complete submission text file 0000950170-24-093343.txt   6872547

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pmvp-20240630.xsd EX-101.SCH 934785
72 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20240630_htm.xml XML 1214986
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 241186131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)